SCN5A Mutation can be divided into gain-of-function and loss-of-function mutation, leading to an increase or decrease in sodium ion influx and an acceleration or delay in channel inactivation, responsible for about 5–10% of LQTS patients and ~30% of patients with BrS, respectively (15, 16). This evidence concerns the gene SCN5A and familial long QT syndrome.